ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,315Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 143

$392K Total Retail Price of All Prescriptions

Rank: 45 out of 143

306 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 306 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 306 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 4,550 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
SIMVASTATIN 251 212 1 2
LISINOPRIL 160 150 2 1
AMLODIPINE BESYLATE 156 156 3 4
ATORVASTATIN CALCIUM 148 111 4 7
HYDROCHLOROTHIAZIDE 136 131 5 10
METFORMIN HCL 136 129 5 8
PRAVASTATIN SODIUM 133 132 7 9
LOSARTAN POTASSIUM 122 119 8 19
OMEPRAZOLE 109 75 9 5
LEVOTHYROXINE SODIUM 105 98 10 3
HYDROCODONE-ACETAMINOPHEN 104 63 S3 11 20
GABAPENTIN 101 71 12 18
FLUTICASONE PROPIONATE 90 59 13 37
GLIMEPIRIDE 81 75 14 27
ATENOLOL 81 81 14 11
ZOLPIDEM TARTRATE 79 43 16 13
FUROSEMIDE 71 71 17 6
INDAPAMIDE 58 58 18 134
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 51 19 21
ALENDRONATE SODIUM 55 51 19 40
WARFARIN SODIUM 53 50 21 15
ALLOPURINOL 53 53 21 39
SYNTHROID 52 52 23 24
PANTOPRAZOLE SODIUM 51 37 24 43
FINASTERIDE 51 51 24 97
ADVAIR DISKUS 51 42 24 42
DIOVAN 51 51 24 26
COMBIVENT 51 50 24 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.